HomeCompareSOAN vs JNJ

SOAN vs JNJ: Dividend Comparison 2026

SOAN yields 2926.54% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SOAN wins by $359018844172.08M in total portfolio value
10 years
SOAN
SOAN
● Live price
2926.54%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$359018844172.10M
Annual income
$336,406,424,515,852,000.00
Full SOAN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SOAN vs JNJ

📍 SOAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSOANJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SOAN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SOAN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SOAN
Annual income on $10K today (after 15% tax)
$248,756.22/yr
After 10yr DRIP, annual income (after tax)
$285,945,460,838,474,200.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SOAN beats the other by $285,945,460,838,473,500.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SOAN + JNJ for your $10,000?

SOAN: 50%JNJ: 50%
100% JNJ50/50100% SOAN
Portfolio after 10yr
$179509422086.06M
Annual income
$168,203,212,257,926,430.00/yr
Blended yield
93.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SOAN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SOAN buys
0
JNJ buys
0
No recent congressional trades found for SOAN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSOANJNJ
Forward yield2926.54%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$359018844172.10M$20.0K
Annual income after 10y$336,406,424,515,852,000.00$827.78
Total dividends collected$357453358331.05M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SOAN vs JNJ ($10,000, DRIP)

YearSOAN PortfolioSOAN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$303,354$292,654.38$10,676$355.77+$292.7KSOAN
2$8,621,597$8,297,007.96$11,407$389.39+$8.61MSOAN
3$229,606,638$220,381,528.81$12,198$426.53+$229.59MSOAN
4$5,730,824,286$5,485,145,183.21$13,056$467.62+$5730.81MSOAN
5$134,081,013,550$127,949,031,564.74$13,987$513.12+$134081.00MSOAN
6$2,941,181,334,559$2,797,714,650,059.88$14,998$563.56+$2941181.32MSOAN
7$60,502,443,340,752$57,355,379,312,773.84$16,098$619.52+$60502443.32MSOAN
8$1,167,397,285,836,126$1,102,659,671,461,521.60$17,295$681.69+$1167397285.82MSOAN
9$21,133,102,482,474,430$19,883,987,386,629,780.00$18,599$750.82+$21133102482.46MSOAN
10$359,018,844,172,099,700$336,406,424,515,852,000.00$20,022$827.78+$359018844172.08MSOAN

SOAN vs JNJ: Complete Analysis 2026

SOANStock

AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.

Full SOAN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SOAN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SOAN vs SCHDSOAN vs JEPISOAN vs OSOAN vs KOSOAN vs MAINSOAN vs ABBVSOAN vs MRKSOAN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.